Table 1.

Demographic and clinical characteristics of the study population according to treatment group on day 0.

	Artesunate-amodiaquine N = 360	Artesunate-mefloquine N = 145	Artemether-lumefantrine (four-doses) N = 140	Artemether-lumefantrine (six-doses) N = 149	Amodiaquine-sulphadoxine-pyrimethamine N = 161
Mean age (yrs)	15	15	12	13	12
Range	1–75	2–65	2–63	2–60	2–51
Mean wt (kg)	36	37	32	35	37
Range	5–102	11–110	12–83		6–89
Mean Parasitaemia (parasites/μL)	39800	27000	22000	15398	27000
Hb < 12 g/dL	68.6%	62.5%	96.7%	68.6%	70.3%
SGOT > 30 UI/L	15.2%	0%	9.7%	17.1%	0%
SGPT > 35 UI/L	0%	0%	0%	2.8%	0%
Creatininemia > 14 mg/L	0%	0%	0%	30%	0%